A New York State court judge tossed a widely publicized lawsuit in which Teva Pharmaceuticals accused two brothers of fraud in connection with the $2.3 billion sale of their Mexican pharmaceutical company to the Israeli drug maker.
The decision caps an embarrassing episode for Teva, which hailed its purchase two years ago of Rimsa, one of the largest independent drug makers in Mexico, as “a significant platform for growth” in the second-largest market in Latin America.
About the Author Reprints
